{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:48:40Z","timestamp":1787759320506,"version":"build-2784847793"},"reference-count":40,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IDR"],"DOI":"10.2147\/idr.s425061","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T05:00:31Z","timestamp":1694149231000},"page":"6005-6015","source":"Crossref","is-referenced-by-count":12,"title":["In vitro Antimicrobial Activity and Dose Optimization of Eravacycline and Other Tetracycline Derivatives Against Levofloxacin-Non-Susceptible and\/or Trimethoprim-Sulfamethoxazole-Resistant Stenotrophomonas maltophilia"],"prefix":"10.2147","volume":"Volume 16","author":[{"given":"Jie","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangcun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"S335","DOI":"10.1093\/cid\/ciu612","volume":"59","author":"Perez","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3389\/fmicb.2015.00893","volume":"6","author":"Chang","year":"2015","journal-title":"Front Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00405-19","volume":"10","author":"Mojica","year":"2019","journal-title":"mBio"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1128\/AAC.00264-16","volume":"60","author":"Mojica","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/1120009X.2017.1378834","volume":"30","author":"Hu","year":"2018","journal-title":"J Chemother"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.cmi.2018.11.008","volume":"25","author":"Ko","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00788-19","volume":"63","author":"Nys","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1093\/jac\/dky279","volume":"73","author":"Sader","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01603-19","volume":"58","author":"Biagi","year":"2020","journal-title":"J Clin Microbiol"},{"key":"ref10","first-page":"1","volume":"63","author":"Flamm","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","first-page":"1","volume":"64","author":"Morrissey","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s40265-016-0545-8","volume":"76","author":"Zhanel","year":"2016","journal-title":"Drugs"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/ajhp\/zxab451","volume":"79","author":"Zidaru","year":"2022","journal-title":"Am J Health Syst Pharm"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"434","DOI":"10.5005\/jp-journals-10071-23241","volume":"23","author":"Baidya","year":"2019","journal-title":"Indian J Crit Care Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1183\/09031936.05.00096704","volume":"25","author":"Pathmanathan","year":"2005","journal-title":"Eur Respir J"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"826","DOI":"10.47102\/annals-acadmedsg.V37N10p826","volume":"37","author":"Kwa","year":"2008","journal-title":"Ann Acad Med Singapore"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e924577","DOI":"10.12659\/AJCR.924577","volume":"21","author":"Oladunjoye","year":"2020","journal-title":"Am J Case Rep"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1513\/AnnalsATS.201608-641CME","volume":"13","author":"Erb","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"ref19","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. CLSI document M100-Ed32. Wayne, PA: Clinical and Laboratory Standards Institute; 2022."},{"key":"ref20","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. CLSI document M07-Ed11. Wayne, PA: Clinical and Laboratory Standards Institute; 2018."},{"key":"ref21","unstructured":"Wyeth Pharmaceuticals Inc. Tygacil\u00ae (Tigecycline) for Injection. Philadelphia (PA): Wyeth Pharmaceuticals Inc; 2013."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1111\/bcp.14692","volume":"87","author":"Zhou","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1128\/AAC.01615-10","volume":"56","author":"Bhavnani","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00045391-199905000-00006","volume":"6","author":"Yamamoto","year":"1999","journal-title":"Am J Ther"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1128\/JCM.01498-13","volume":"51","author":"Maaland","year":"2013","journal-title":"J Clin Microbiol"},{"key":"ref26","volume-title":"Antimicrobial Pharmacodynamics in Theory and Clinical Practice","year":"2007"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/jac\/dki079","volume":"55","author":"Mouton","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","volume":"74","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s10096-019-03590-3","volume":"38","author":"Lee","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s40262-019-00767-z","volume":"58","author":"McCarthy","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.ijantimicag.2018.01.001","volume":"51","author":"Thabit","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1001\/jamasurg.2016.4237","volume":"152","author":"Solomkin","year":"2017","journal-title":"JAMA Surg"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/cid\/ciy1029","volume":"69","author":"Solomkin","year":"2019","journal-title":"Clin Infect Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1128\/AAC.02036-13","volume":"58","author":"Connors","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01174-18","volume":"62","author":"Newman","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"ref36","unstructured":"Weiss WJ, Pulse M, Renick P, et al. Efficacy of fluorocyclines TP-434 in the neutropenic thigh infection model is predicted by AUC\/MIC. Poster presented at: 50th Annual interscience conference on antimicrobial agents and chemotherapy; Boston; 2010."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000048494","volume":"47","author":"Watanabe","year":"2001","journal-title":"Chemotherapy"},{"key":"ref38","first-page":"1","volume":"61","author":"Zhou","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00275-18","volume":"62","author":"Petraitis","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"ref40","unstructured":"Cornely OA, Arenz D, Barraud O, et al. Phase I study to evaluate the safety and pharmacokinetics of single and multiple ascending doses of intravenous minocycline in healthy adult subjects. Poster presented at: IDWeek 2018; San Francisco, CA; 2018."}],"container-title":["Infection and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=92643","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=92643","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T05:00:36Z","timestamp":1694149236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/in-vitro-antimicrobial-activity-and-dose-optimization-of-eravacycline--peer-reviewed-fulltext-article-IDR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":40,"URL":"https:\/\/doi.org\/10.2147\/idr.s425061","relation":{},"ISSN":["1178-6973"],"issn-type":[{"value":"1178-6973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}